Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial
Sanyal, Arun J., et al. Nature Medicine 29.2 (2023): 392-400.
Categories: Publications
Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis
Noureddin, Mazen, et al. Alimentary Pharmacology & Therapeutics 57.4 (2023): 409-417.
Digital pathology with artificial intelligence analyses provides greater insights into treatment-induced fibrosis regression in NASH
Naoumov, Nikolai V., et al. Journal of Hepatology 77.5 (2022): 1399-1409.
Developing a New qFIBS Model Assessing Histological Features in Pediatric Patients With Non-alcoholic Steatohepatitis
Liu, Feng, et al. Frontiers in Medicine 9 (2022): 925357.
Artificial Intelligence Improves Pathologist Agreement for Fibrosis Scores in Nonalcoholic Steatohepatitis Patients
Soon, Gwyneth ST, et al. Clinical Gastroenterology and Hepatology (2022).
Breakthroughs in therapies for NASH and remaining challenges
Ratziu, Vlad, et al. Journal of Hepatology 76.6 (2022): 1263-1278.
Multi-photon microscopy for the evaluation of interstitial fibrosis in extended criteria donor kidneys: A proof-of-concept study
So, Wei Zheng, et al. Clinical Transplantation 36.8 (2022): e14717.
Valproic acid modulates collagen architecture in the postoperative conjunctival scar
Seet, Li-Fong, et al. Journal of Molecular Medicine 100.6 (2022): 947-961.
Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD
Brunt, Elizabeth M., et al. Journal of hepatology 76.5 (2022): 1030-1041.
Effects of Valproic Acid and Mitomycin C Combination Therapy in a Rabbit Model of Minimally Invasive Glaucoma Surgery
Seet, Li-Fong, et al. Translational Vision Science & Technology 11.1 (2022): 30-30.